[
  {
    "ts": "2025-11-19T13:30:00+00:00",
    "headline": "Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes",
    "summary": "SAN DIEGO, November 19, 2025--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the FDA has cleared Dexcom Smart Basal, the first and only CGM-integrated basal insulin dosing optimizer designed for adults with Type 2 diabetes on glargine U-100 long-acting insulin therapy.1 Dexcom Smart Basal will use Dexcom G7 15 Day sensor data and logged doses to calculate personalized daily recommendations to guide users towards a more effective long-acting insulin dose, as",
    "url": "https://finance.yahoo.com/news/dexcom-smart-basal-receives-fda-133000624.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "a652a544-ab5e-3964-a4ca-d9135583f4d2",
      "content": {
        "id": "a652a544-ab5e-3964-a4ca-d9135583f4d2",
        "contentType": "STORY",
        "title": "Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes",
        "description": "",
        "summary": "SAN DIEGO, November 19, 2025--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the FDA has cleared Dexcom Smart Basal, the first and only CGM-integrated basal insulin dosing optimizer designed for adults with Type 2 diabetes on glargine U-100 long-acting insulin therapy.1 Dexcom Smart Basal will use Dexcom G7 15 Day sensor data and logged doses to calculate personalized daily recommendations to guide users towards a more effective long-acting insulin dose, as",
        "pubDate": "2025-11-19T13:30:00Z",
        "displayTime": "2025-11-19T13:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/517bb5a465d571baf79a211e1b66a5b3",
          "originalWidth": 329,
          "originalHeight": 480,
          "caption": "Dexcom Smart Basal is designed to make basal insulin initiation and management simpler and more personalized for users and their healthcare providers.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vr0k9d4I2oA_U1DCkV64nw--~B/aD00ODA7dz0zMjk7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/517bb5a465d571baf79a211e1b66a5b3.cf.webp",
              "width": 329,
              "height": 480,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2kAbcXZEykybGNRsO8kPFg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/517bb5a465d571baf79a211e1b66a5b3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/dexcom-smart-basal-receives-fda-133000624.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/dexcom-smart-basal-receives-fda-133000624.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DXCM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]